Summary: Retatrutide peptide is not approved in the UK and cannot be legally obtained outside a regulated clinical trial, as it has not received MHRA or EMA marketing authorisation
Medical Management of Obesity: A Comprehensive Review of Food and Drug Administration (FDA)-Approved and Investigational Therapies
When blood sugar is low, GIP can actually increase glucagon secretion, which helps prevent hypoglycemia
GLP-1 medications, like semaglutide, work by regulating appetite and blood sugar, leading to steady, safe weight loss
Additionally, GIPR antagonists also exhibit improvement of metabolism on obese mice 57 and GIPR agonists or antagonists both show therapeutical effects in combination with GLP-1R agonists
And, unfortunately, people are stigmatized for having extra weight